ICOVIR-7
AXP000051.1 · Oncolytic virus
- Platform
- adenovirus (Ad5, modified E2F-1 promoter with extra E2F sites, Delta-24, RGD fiber)
- Originator
- IDIBELL / Institut Catala d'Oncologia (Ramon Alemany)
Names
| Name | Type | Source |
|---|---|---|
| ICOVIR-7 | preferred name, code | curator, paper |
Virus
- Role
- Oncolytic
- Family
- Adenoviridae
- Virus
- human adenovirus 5 (NCBI Taxonomy 28285)
- Strain
- Ad5 (ICOVIR-7)
- Replication
- conditionally replicating
- Modifications
- E2F-1 promoter with four extra E2F binding sites; E1A-Delta24; RGD-4C fiber
- Route
- intratumoral
- Source
- evidence
Approvals
No regulatory approval recorded.
Clinical trials (0)
No trial in the latest ClinicalTrials.gov snapshot names this program.
Recent changes
No changes recorded in its trials yet.
Clinical papers
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 20501623 | Oncolytic adenovirus ICOVIR-7 in patients with advanced and refractory solid tumors. | Clinical cancer research : an official journal of the American Association for Cancer Research | 2010 | name in title: ICOVIR-7 |
Other papers
Preclinical studies, reviews and other papers that name it.
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 19710704 | A modified E2F-1 promoter improves the efficacy to toxicity ratio of oncolytic adenoviruses. | Gene therapy | 2009 | name in abstract: ICOVIR-7 |
Notes
Given to 21 patients with advanced solid tumours in Finland under the Advanced Therapy Access Program (ATAP), an individualised-treatment programme rather than a registered clinical trial (Nokisalmi et al., Clin Cancer Res 2010). No registered trial found.
How to cite
ICOVIR-7 (AXP000051.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000051.html
Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.